Article
Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib.
Yonsei medical journal - 1 Sept 2012
Jung Minkyu, Kim Se Hyun, Hong Soojung, Kang Young Ae, Kim Se Kyu, Chang Joon, Rha Sun Young, Kim Joo Hang, Kim Dae Joon, Cho Byoung Chul
Abstract excerpt
PURPOSE: The prognostic and predictive value of pretreatment serum levels of carcinoembryonic antigen (CEA) and cytokeratin-19 fragments (CYFRA 21-1) were assessed in advanced non-small cell lung cancer (NSCLC) patients treated with gefitinib or erlotinib. MATERIALS AND METHODS: Pretreatment CEA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.